2019icksh.org/2019/main · · chronic myeloid leukemia · Quality of lifemyeloproliferative...

www.icksh.org

2019 KOREAN SOCIETY OFHEMATOLOGY INTERNATIONAL CONFERENCE

& 60th ANNUAL MEETING

MARCH 14 - 16, 2019Grand Walkerhill Hotel, Seoul, Korea

2019

Welcome message

Dear colleagues,

on behalf of the organizing committee, it is our great honor and pleasure to invite you to the 2019 KsH International

conference & the 60th annual meeting, hosted by the Korean society of Hematology (KsH), which will be held in

seoul, Korea from march 14 to 16, 2019.

The Korean society of Hematology successfully held the first IcKsH in conjunction with BTg last year, surpassing

all expectations. Now, the organizing committee is positioning the KsH to lead the field of hematologic diseases

through the relationships and cooperation of many countries by sharing our treatment technology with the world.

The IcKsH will offer the unique opportunity to learn about the latest findings and research from renowned specialists

as well as to exchange ideas and information on the most recent trends.

our programs will include benign hematologic diseases, various types of hematologic malignancies, coagulation/

thrombosis related disorders and transfusion medicine through plenary lectures, as well as scientific and education

sessions. In addition, a variety of stimulating social programs has been planned so participants can enjoy the

fascinating Korean culture and share our warm spirit of friendship.

We look forward to welcoming you and your active participation at IcKsH 2019 in seoul, Korea!

Hwi-joong Yoon Congress Chair (2018)The Korean Society of Hematology

chan-Jeoung ParkCongress Chair (2019)The Korean Society of Hematology

Hyeoung-Joon KimPresident (2018)The Korean Society of Hematology

Bin choPresident (2019)The Korean Society of Hematology

KeY sPeaKers

march 14 (Thu.) Plenary lectures I – gene Therapy in Hematology

application of crIsP/cas-9 in blood disease

Matthew H. Porteus Stanford University, USA

gene therapy for hemophilia

Katherine High Spark Therapeutics Inc., USA

march 15 (Fri.)Plenary lectures II – clinical Hematology lecture

Breakthroughs in the treatment of aplastic anemia

Neal Young NIH, USA

Breakthroughs in the treatment of DlBcl

Bertrand Coiffier Retired Hematology Department, Past-President of GELA, President of ELI, France

march 16 (sat.)Plenary lectures III – genomics in lymphoid malignancies

genomics in all

Charles Mullighan St. Jude Children's Research Hospital, USA

march 14 (Thu.) Presidential symposium

stem cells in human aml

Ravindra Majeti Stanford University, USA

optimal treatment of adolescents and young adult all

Ching-Hon Pui St. Jude Children's Research Hospital, USA

Program _marcH 14 (Thu.), 2019

VISTA 1 VISTA 2 VISTA 3 GrAnd HAll

08:00-09:00 reGISTrATIon

09:00-10:30

[JS01]KAI-KSH JoInT

SeSSIon

[SS01]Bone MArrow

FAIlure

IMMunoTHerApeuTIcS In Blood dISeASe

Immune checkpoint inhibitor in cancer

(seung-Woo lee, Korea)

cAr-T(chan Hyuk Kim, Korea)

cytotoxic T lymphocyte therapy

(Hyewon lee, Korea)

Immune checkpoint inhibitor in lymphoma

(Dok Hyun Yoon, Korea)

paroxysmal nocturnal hemoglobinuria in bone

marrow failure(Jun Ho Jang, Korea)

Germ line mutations in inherited BM failure

(Jean soulier, France)

Telomere length and somatic mutations in

aplastic anaemia(Dong soon lee, Korea)

10:30-10:45 coffee Break

10:45-11:45

plenAry lecTure IGene THerApy In HeMAToloGy

Application of crISpr/cas-9 in blood disease(matthew H.Porteus, Usa)

Gene therapy for hemophilia(Katherine High, Usa)

11:45-12:45

preSIdenTIAl SyMpoSIuM

Stem cells in human AMl(ravindra majeti, Usa)

optimal treatment of adolescents and young adult All(ching-Hon Pui, Usa)

12:45-13:40[lS01]

luncHeon SyMpoSIuM

[lS02]luncHeon

SyMpoSIuM

[lS03]luncHeon

SyMpoSIuM

13:40-14:40[AS01]

ASIAn HeMAToloGy SyMpoSIuM

[AS02]ASIAn HeMAToloGy

SyMpoSIuM

Program _marcH 14 (Thu.), 2019


14:55-16:25

[JS02]KoGo-KSH JoInT

SeSSIon

[SS02]MulTIple MyeloMA

[SS03]TrAnSplAnTATIon/

cell THerApy

[eS01]Iron MeTABolISM

GenoMIcS For precISIon

HeMAToloGy

understanding angioimmunoblastic T-cell lymphoma:�from genomics

to animal pathology(Jaesang Kim, Korea)

Genomic pathogenesis of epstein–barr virus (eBV)�-

induced diffuse large B cell lymphoma

(sung-Yup cho, Korea)

current status of precision hematology

(Young-Uk cho Korea)

clinical application of precision hematology

(Joon-Ho moon, Korea)

High risk MM identifyed by genomic analysis

(gareth morgan, UK)

what role does bone marrow microenvironment

play on MM cells(Yusuke Furukawa, Japan)

Antigen-mediated regulation in MM

(madhav Dhodapkar, Usa)

TK cell therapy(chiara Bonini, Italy)

updates on cAr T cell therapy for multiple

myeloma(Jesús Berdeja, Usa)

new insights into cancer vaccine strategies(larry Kwak, Usa)

Iron metabolism in hemoglobinopathies

(Vip Viprakasit, Thailand)

deferasirox for iron overload patients:�

preserving organ functions (Norbert gattermann,

germany)

Managing side effects in iron chelation therapy

(Heather leitch, canada)

16:25-16:40 Break

16:40-18:10

[SS04]MyeloprolIFerATIVe

neoplASM

[SS05]BleedInG dISorder/

THroMBoSIS

[SS06]pedIATrIc dISeASe

[eS02]IndolenT

lyMpHoMA

clinical significance of genetic stratification of

Mpn patients(robert Kralovics, austria)

Molecular mechanism of Mpn development by

mutant calreticulin(Norio Komatsu, Japan)

Interferon treatment for Mpn

(Jean-Jacques Kiladjian, France)

Gene therapy for hemophilia

(glenn F. Pierce, Usa)

Individualized treatment for hemophilia :� population

pharmacokinetics approach

(cindy Yeung, canada)

Mechanisms of cancer-associated thrombosis(Nigel mackman, Usa)

Inherited hematologic malignancies

(lucy godley, Usa)

GATA2 leukemogenesis (Jean Donadieu, France)

roles of monosomy 7 and SAMd9/SAMd9l

mutationsin myeloid leukemogenesis

(Hirotaka matsui, Japan)

Mantle cell lymphoma(mats Jerkeman, sweden)

Follicular lymphoma(gilles salles, France)

chronic lymphocytic leukemia/

small lymphocytic lymphoma

(Wei Xu, china)

18:30-20:00 welcoMe recepTIon

* SeSSIon code[JS] Joint symposium[SS] scientific session[eS] educational session[AS] asian Hematology symposium[lS] luncheon symposium

Program _marcH 15 (Fri.), 2019


08:00-09:00 reGISTrATIon

09:00-10:30

[JS03]eHA-KSH JoInT SyMpoSIuM I

[SS07]BenIGn

HeMAToloGy

[SS08]HISTIocyToSIS

[eS03]AcuTe

lyMpHoBlASTIc leuKeMIA

MulTIple MyeloMA

Monoclonal antibody for MM

(TBD)

double refractory MM(chang-Ki min, Korea)

experimental therapy except monoclonal Ab (Francesca gay, Italy)

Treatment of high risk r/r MM

(Jin seok Kim, Korea)

Introduction of eurobloodnet and its

activity(maria del mar manu,

spain)

clinical utility of high-throughput sequencing forthe diagnosis of hereditary

hemolytic anemia (myungshin Kim, Korea)

Molecular spectrum of Thalassemia/

hemoglobinopathy(cornelis Harteveld, The

Netherlands)

recent progress in the pathogenesis and

treatment of lcH(carl e. allen, Usa)

Treatment of HlH - today and tomorrow

(Jan-Inge Henter, sweden)

Genetic studies of HlH in Korea

(Jong Jin seo, Korea)

TBd

recent advances in the treatment of adult All(Won-sik lee, Korea)

Mutational landscape of All:�next-generation

sequencing-based mutations scanning

strategy(seung-Tae lee, Korea)


10:45-11:45

plenAry lecTure IclInIcAl HeMAToloGy lecTure

Breakthroughs in the treatment of aplastic anemia(Neal Young, Usa)

Breakthroughs in the treatment of dlBcl(Bertrand coiffier, France)

11:45-12:45[AS03]

ASIAn HeMAToloGy SyMpoSIuM II

poSTer preSenTATIon

12:45-13:40[lS04]

luncHeon SyMpoSIuM

[lS05]luncHeon

SyMpoSIuM

[lS06]luncHeon

SyMpoSIuM


13:50-15:05 orAl I

15:05-16:20 orAl II

16:20-16:35 Break

Program _marcH 15 (Fri.), 2019


16:35-18:05

[SS09]FuTure

InForMATIon AndcoMMunIcATIonS

TecHnoloGIeS(IcT)� BASed MedIcIne

[SS10]AcuTe MyeloId

leuKeMIA/MyelodySplASTIc

SyndroMeS

[SS11]cHronIc MyeloId

leuKeMIA

[eS04]coAGulATIon

deep learning for crISpr-cpf1 research

(sungroh Yoon, Korea)

precision dinner:� Genomes and personal

health records(Ju Han Kim, Korea)

IoT (Jack ahn, Korea)

Genomics of core-binding factor AMl

(Nicolas Duployez, France)

precision medicine in AMl in the era of novel agents

(gail roboz, Usa)

MdS:� Integrating biomarker into prognostic

models (amer Zeidan, Usa)

Is cMl a single hit disorder?

(Dennis Kim, canada)

nGS based ABl1 kinase domain mutation detection

(simona soverini, Italy)

precision medicine and immunity in cMl

(satu mustjoki, Finland)

Global hemostasis test guided management of

hemorrhage and coagulopathy

(marc maegele, germany)

clinical application of clot waveform analysis

in hemophilia treatment(Keiji Nogami , Japan)

Thrombin generation assay (Bas de laat, The

Netherlands)

18:30-20:00 GAlA dInner


Program _marcH 16 (sat.), 2019


07:20-08:20 BuSIneSS MeeTInG

08:20-08:30 AwArd cereMony

08:30-09:00worKInG pArTy

reporTS

09:00-10:30

[JS04]eHA-KSH JoInT SyMpoSIuM II

[SS12]cHIldHood AcuTe

lyMpHoBlASTIc leuKeMIA

[SS13]lyMpHoMA

[SS14]AdVAnceS In TecHnoloGy

cHronIc MyeloId leuKeMIA

real-world experiences of TFr in europe

(TBD)

Treatment-free remission in cMl

(Hawk Kim, Korea)

TKI-related cardiovascular toxicities in europe (susanne saußele,

germany)

Management of TKI-related toxicities

(Jee Hyun Kong, Korea)

Treatment of childhood All with IKZF1 deletion

(allen eng Juh Yeoh, singapore)

outcome of children with newly diagnosed

All treated with cclG-All 2008

(chi-kong li, Hong Kong)

recent updates of prospective trials in Japan

(Yasuhiro okamoto, Japan)

pathogenesis of eBV-associated

lymphoproliferative disorders

(Hiroshi Kimura, Japan)

Molecular understanding of peripheral T-cell

lymphoma(Iqbal Javeed, Usa)

clinical application of cell-free dnA in lymphoma(seok Jin Kim, Korea)

droplet Microfluidics in antibody discovery,

immunerepertoiresequencing

and personalized cancer therapy

(christoph merten, germany)

Applications of single-cell mass cytometryin hematologic malignancies

(gregory Behbehani, Usa)

prediction of acute myeloid leukemia risk

in healthy individuals(liran shlush, Israel)


10:45-11:45

plenAry lecTure IIIGenoMIcS In lyMpHoId MAlIGnAncIeS

Genomics in All(charles mullighan, Usa)

TBd

11:45-12:30 AwArd cereMony & cloSInG


optional Tours

IcKsH2019 will have exciting tour programs. The tours aim at showing conference participants the historical sites and cultural wealth of the city. There is an additional charge to join the tour programs.

· royal palace & Shopping Full-day Tour

· world cultural Heritage Morning Tour

· charming Korea Afternoon Tour

· Fantastic Seoul night View Tour

· Morning dMZ Tour

socIal Program

· date & Time: march 14 evening

· Venue: re:Bar, Vista Walkerhill seoul (1F)

· Fee: Included in the registration fee

· Menu: standing cocktail

celebrate your first day of the congress with a lively performance and standing buffet at the IcKsH 2019 Welcome reception and enjoy together with colleagues from all over the world.

Welcome reception

· date & Time: march 15 evening

· Venue: Walkerhill Theater, grand Walkerhill (B1)

· Fee: Included in the registration fee

· Menu: Western Full course

Please join us and share an unforgettable evening. The banquet will be the ideal place for networking among participants. enjoy the climax of IcKsH 2019 with an amazing dinner.

gala Dinner

call For aBsTracT

The IcKsH 2019 organizing committee cordially invites you to submit abstracts for oral and poster presentations.

all conference abstracts must be submitted online via the online submission system (www.icksh.org). submitted

abstracts will be reviewed by the scientific Program committee. The presentation type may be changed following

review by the scientific committee.

only outstanding selected abstracts will be reviewed on-site for the Best Presentation award. Therefore, please

submit your abstracts carefully.

Important Dates

abstract submission Topics· acute lymphoblastic leukemia

· acute myeloid leukemia

· myelodysplastic syndrome

· anemia and other red cell disorders

· Bone marrow failure syndromes

· chronic myeloid leukemia

· myeloproliferative neoplasm

· Histiocytosis and other dendritic cell neoplasm

· lymphoma

Notification of acceptance· all submitted abstracts will be reviewed by the scientific Program committee according to reviewing procedures.

· Notification of acceptance will be sent by e-mail to corresponding, presenting and abstract submitting authors by

December 31, 2018.

· The presenting author should reply to the acceptance notification for confirmation of attendance.

abstract Withdrawal· If the presenting author of an accepted abstract does not register by February 15, 2019, the abstract will be automatically

withdrawn from the final program.

· If you have to withdraw an abstract, please notify the secretariat ([email protected]) in writing as soon as possible.

· multiple myeloma

· Platelet/Hemostasis

· cellular therapy

· Hematopoiesis/stem cell biology

· Hematopoietic stem cell transplantation

· laboratory Hematology

· Quality of life

· Transfusion medicine

· others

Dec. 9, 2018

Deadline forabstract submission

Dec. 31, 2018

Notification ofabstract acceptance

JaN. 15, 2019

Deadline for late Breaking abstract

TraVel graNTs

Travel grant will be awarded to especially presenters from low-income countries up to 100 participants. The

secretariat will contact awardees individually. awardees will receive a travel grant in the amount of UsD 1,500 on-site.

Download the application form on the IcKsH website and return the application form to the IcKsH 2019 secretariat

via e-mail ([email protected]) by January 15, 2019.

eligibility1. Presenters of accepted abstracts are eligible for the travel grant.

2. abstracts must be presented by awardees at IcKsH 2019.

3. Presenters need to register for the conference. (registration fees will not be waived.)

4. Participants from low-income economies, lower-middle-income economies or upper-middle-income economies

qualify as classified by the World Bank. eligible countries is noticed at the IcKsH 2019 website (www.icksh.org).

YoUNg INVesTIgaTor aWarD

· The IcKsH 2019 organizing committee will provide financial support to individuals to attend the IcKsH 2019.

outstanding papers in oral or poster presentation at IcKsH 2019 would be chosen to receive this award (UsD 1,500).

· Download the application form on the IcKsH website and return the application form to the IcKsH 2019 secretariat

via e-mail ([email protected]) by January 15, 2019.

regIsTraTIoN

all participants are requested to register via the online submission system (www.icksh.org) and advised to register

in advance to receive the Pre-registration discount by February 15, 2019.

registrants who completed payment are able to download the invitation letter from the online system (www.icksh.org).

However, registration does not guarantee the applicant a visa.

registration Feescategory early-bird registration

(by Feb. 15, 2019)Pre-registration(Feb. 16-28, 2019)

on-site registration(March 14 -16, 2019)

oVerSeAS

general UsD 100 UsD 200 UsD 200

resident/ Trainee/ Nurse/ student UsD 50 UsD 100 UsD 100

doMeSTIc

KsH member KrW 100,000 KrW 200,000 KrW 200,000

Non-member KrW 200,000 KrW 300,000 KrW 300,000

resident/ Trainee/ Nurse/ student KrW 50,000 KrW 50,000 KrW 50,000

* students are requested to submit proof of enrollment or student ID/certificate to verify their status to the secretariat by e-mail.

VenueGrand walkerhill Hotel04963) Walkerhill Hotel, 177 Walkerhill-ro, gwangjin-gu, seoul, KoreaTel. +82.2.455.5000 https://www.walkerhill.com/grandwalkerhillseoul

IcKSH 2019 Secretariat

1F, Haeoreum B/D, 16, Yeoksam-ro 17 gil, Yeoksam-dong, gangnam-gu, seoul, Korea Tel. +82-2-566-6031, 6033 Fax. +82-2-566-6087 e-mail. [email protected]

2019icksh.org/2019/main · · chronic myeloid leukemia · Quality of lifemyeloproliferative...

Documents

Transcript of 2019icksh.org/2019/main · · chronic myeloid leukemia · Quality of lifemyeloproliferative...